Eton Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Eton Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2023.
  • Eton Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$52K, a 108% decline year-over-year.
  • Eton Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$110K, a 144% decline year-over-year.
  • Eton Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $503K.
  • Eton Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$761K, a 24.4% increase from 2021.
  • Eton Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.01M, a 17.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $503K +$1.26M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$761K +$245K +24.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$1.01M -$147K -17.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 -$859K -$1.14M -406% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $281K +$117K +71.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-16
2018 $164K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.